![Variations to the current ECCO/ESPGHAN guidance as proposed by the RAND... | Download Scientific Diagram Variations to the current ECCO/ESPGHAN guidance as proposed by the RAND... | Download Scientific Diagram](https://www.researchgate.net/publication/344057553/figure/fig1/AS:932810911141899@1599410860409/ariations-to-the-current-ECCO-ESPGHAN-guidance-as-proposed-by-the-RAND-appropriateness.png)
Variations to the current ECCO/ESPGHAN guidance as proposed by the RAND... | Download Scientific Diagram
![ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/04/news-ecco-1080x675.jpg)
ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease
![Activation of FXR Restores Expression of Genes Dysregulated in Human IBD and Suppresses TNFα and IL-6 Signaling Pathways in Adoptive Transfer Colitis Model - Metacrine Activation of FXR Restores Expression of Genes Dysregulated in Human IBD and Suppresses TNFα and IL-6 Signaling Pathways in Adoptive Transfer Colitis Model - Metacrine](https://metacrine.com/wp-content/uploads/2021/07/ECCO2021-Poster-FINAL-thumb.jpg)
Activation of FXR Restores Expression of Genes Dysregulated in Human IBD and Suppresses TNFα and IL-6 Signaling Pathways in Adoptive Transfer Colitis Model - Metacrine
![Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2022/03/Feature-Image-Gastroenterology-11-Supplement-1-ECCO.jpg)
Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal
![ECCO 2022 Insights: Treatment developments for irritable bowel disease (IBD) and rheumatology - European Medical Journal ECCO 2022 Insights: Treatment developments for irritable bowel disease (IBD) and rheumatology - European Medical Journal](https://embed-ssl.wistia.com/deliveries/f0344b3407ed4e8e865edf5a54b4ad9a/file..jpg?image_crop_resized=1920x1080)